Mirador Capital Partners LP cut its holdings in UnitedHealth Group Inc (NYSE:UNH) by 0.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,248 shares of the healthcare conglomerate’s stock after selling 60 shares during the quarter. Mirador Capital Partners LP’s holdings in UnitedHealth Group were worth $2,131,000 at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in UNH. Nuveen Asset Management LLC increased its stake in shares of UnitedHealth Group by 1,354.6% in the 2nd quarter. Nuveen Asset Management LLC now owns 8,540,562 shares of the healthcare conglomerate’s stock worth $2,083,983,000 after purchasing an additional 7,953,416 shares in the last quarter. Johanson Financial Advisors Inc. increased its stake in shares of UnitedHealth Group by 28,935.9% in the 4th quarter. Johanson Financial Advisors Inc. now owns 3,384,419 shares of the healthcare conglomerate’s stock worth $11,512,000 after purchasing an additional 3,372,763 shares in the last quarter. Boston Partners increased its stake in shares of UnitedHealth Group by 160.8% in the 2nd quarter. Boston Partners now owns 2,550,998 shares of the healthcare conglomerate’s stock worth $622,942,000 after purchasing an additional 1,572,711 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC increased its stake in shares of UnitedHealth Group by 63.3% in the 2nd quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 1,705,888 shares of the healthcare conglomerate’s stock worth $416,254,000 after purchasing an additional 661,064 shares in the last quarter. Finally, Nomura Holdings Inc. increased its stake in shares of UnitedHealth Group by 474.5% in the 3rd quarter. Nomura Holdings Inc. now owns 561,936 shares of the healthcare conglomerate’s stock worth $122,846,000 after purchasing an additional 464,121 shares in the last quarter. 85.44% of the stock is currently owned by institutional investors and hedge funds.
UNH has been the subject of several analyst reports. ValuEngine upgraded UnitedHealth Group from a “sell” rating to a “hold” rating in a research note on Wednesday, October 2nd. Evercore ISI started coverage on UnitedHealth Group in a research note on Tuesday, December 10th. They issued a “buy” rating and a $285.00 price objective for the company. Morgan Stanley reiterated a “buy” rating and issued a $312.00 price target (up previously from $294.00) on shares of UnitedHealth Group in a research note on Friday, November 22nd. JPMorgan Chase & Co. increased their price target on UnitedHealth Group from $276.00 to $361.00 and gave the stock an “overweight” rating in a research note on Friday, December 20th. Finally, Jefferies Financial Group lowered UnitedHealth Group from a “buy” rating to a “hold” rating and cut their price target for the stock from $300.00 to $235.00 in a research note on Thursday, October 10th. Five equities research analysts have rated the stock with a hold rating and nineteen have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $313.50.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Wednesday, January 15th. The healthcare conglomerate reported $3.90 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.77 by $0.13. The firm had revenue of $60.90 billion during the quarter, compared to analyst estimates of $61.17 billion. UnitedHealth Group had a return on equity of 25.30% and a net margin of 5.57%. The business’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same quarter last year, the business posted $3.28 earnings per share. On average, research analysts predict that UnitedHealth Group Inc will post 14.98 earnings per share for the current fiscal year.
In other news, EVP D Ellen Wilson sold 7,400 shares of the firm’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $272.77, for a total transaction of $2,018,498.00. Also, CAO Thomas E. Roos sold 1,177 shares of the firm’s stock in a transaction dated Thursday, November 7th. The shares were sold at an average price of $255.04, for a total value of $300,182.08. Following the transaction, the chief accounting officer now owns 21,687 shares of the company’s stock, valued at approximately $5,531,052.48. The disclosure for this sale can be found here. Company insiders own 0.87% of the company’s stock.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: What is the outlook for the FAANG stocks?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.